Delivery of community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa

Bibliographic Details
Main Authors:	Wang, M, Violette, LR, Dorward, J, Ngobese, H, Sookrajh, Y, Bulo, E, Quame-Amaglo, J, Thomas, KK, Garrett, N, Drain, PK
Format:	Journal article
Language:	English
Published:	Lippincott, Williams & Wilkins 2023

Early antiretroviral therapy is associated with better viral suppression and less HIV drug resistance after implementation of universal treatment in South Africa
by: Dorward, J, et al.
Published: (2019)

Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial
by: Drain, PK, et al.
Published: (2020)

Intimate Partner Violence and HIV Outcomes Among Women Living with HIV in Durban, South Africa
by: Ojeaburu, SO, et al.
Published: (2024)

Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study
by: Dorward, JJ, et al.
Published: (2021)

Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
by: Dorward, J, et al.
Published: (2024)

Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study
by: Dorward, J, et al.
Published: (2017)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
by: Bardon, AR, et al.
Published: (2021)

Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa
by: Lewis, L, et al.
Published: (2021)

Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa
by: Msimango, L, et al.
Published: (2020)

Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa
by: Mthembu, N, et al.
Published: (2020)

Understanding how community antiretroviral delivery influences engagement in HIV care: a qualitative assessment of the Centralised Chronic Medication Dispensing and Distribution programme in South Africa
by: Sarah Tonkin-Crine, et al.
Published: (2020-05-01)

Point-of-care viral load testing and differentiated HIV care
by: Dorward, J, et al.
Published: (2017)

Diagnostic accuracy of the rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load & m-PIMA HIV-1/2 Viral Load in South African clinics
by: Dorward, J, et al.
Published: (2022)

Low CD4 count and educational status predict abnormal cervical smears amongst HIV-positive women initiating antiretroviral therapy in South Africa
by: Nondumiso Mthembu, et al.
Published: (2020-03-01)

Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023)

Conceptualising implementation strategies in HIV research – Authors' reply
by: Drain, PK, et al.
Published: (2020)

Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023)

Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER)
by: Dorward, J, et al.
Published: (2023)

Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV
by: Bodley, N, et al.
Published: (2022)

Long‐term usage patterns and clinical outcomes in a community‐based differentiated antiretroviral therapy delivery programme in South Africa
by: Lewis, L, et al.
Published: (2023)

Provider-led community antiretroviral therapy distribution in Malawi: Retrospective cohort study of retention, viral load suppression and costs.
by: John Songo, et al.
Published: (2023-01-01)

Provider-led community antiretroviral therapy distribution in Malawi: Retrospective cohort study of retention, viral load suppression and costs
by: John Songo, et al.
Published: (2023-01-01)

Long‐term usage patterns and clinical outcomes in a community‐based differentiated antiretroviral therapy delivery programme in South Africa
by: Lara Lewis, et al.
Published: (2023-07-01)

Point-of-care HIV viral load testing: An essential tool for a sustainable global HIV/AIDS response
by: Drain, P, et al.
Published: (2019)

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
by: Dorward, J, et al.
Published: (2020)

Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study
by: Lewis, L, et al.
Published: (2023)

Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
by: Dorward, J, et al.
Published: (2018)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
by: Jienchi Dorward, et al.
Published: (2023-09-01)

Retention in Continuous Care and Sustained Viral Suppression
by: Timothy N. Crawford PhD, MPH, et al.
Published: (2017-01-01)

Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa
by: Stime, K, et al.
Published: (2018)

Feasibility of implementing same-day antiretroviral therapy initiation during routine care in Ekurhuleni District, South Africa: Retention and viral load suppression
by: Nolundi Mshweshwe-Pakela, et al.
Published: (2020-08-01)

Clinical outcomes after extended 12‐month antiretroviral therapy prescriptions in a community‐based differentiated HIV service delivery programme in South Africa: a retrospective cohort study
by: Lara Lewis, et al.
Published: (2023-09-01)

A systematic review of the effectiveness of non- health facility based care delivery of antiretroviral therapy for people living with HIV in sub-Saharan Africa measured by viral suppression, mortality and retention on ART
by: Mohammed Limbada, et al.
Published: (2021-06-01)

Clinical outcomes after Viremia among people receiving dolutegravir vs efavirenz-based first-line antiretroviral therapy in South Africa
by: Asare, K, et al.
Published: (2023)

Work System and Process Designs for Community Pharmacy-Medical Clinic Partnerships to Improve Retention in Care, Antiretroviral Adherence, and Viral Suppression in Persons with HIV
by: Jon C. Schommer, et al.
Published: (2020-07-01)

Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam
by: Suresh Rangarajan, et al.
Published: (2016-04-01)

Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during COVID-19 in South Africa: A qualitative inquiry
by: Tlhaku, K, et al.
Published: (2024)

Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
by: Maganizo B Chagomerana, et al.
Published: (2018-01-01)

Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa
by: Katrina J. Stime, et al.
Published: (2018-05-01)

Delivery of community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa

Similar Items

Similar Items